Home > Financial Ratios > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.081.330.590.840.75

What is the latest Working Capital/Sales ratio of GLAND PHARMA ?

The latest Working Capital/Sales ratio of GLAND PHARMA is 1.08 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.08
Mar20241.33
Mar20230.59
Mar20220.84
Mar20210.75

How is Working Capital/Sales of GLAND PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 1.08
-18.80
Mar2024 1.33
125.42
Mar2023 0.59
-29.76
Mar2022 0.84
12.00
Mar2021 0.75 -

Other Financial Ratios of GLAND PHARMA


Compare Working Capital/Sales ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹30,521.8 Cr -2.4% 8.4% 21% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2.4%

8.4%

21%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses